Inventor · disambiguated record
Jianyan Xu
Also filed as: XU JIANYAN
3 granted patents·6 pending applications·6 citations·filing 2016–2022
55Inventor score
Files withJIANGSU HENGRUI MEDICINE CO4JIANGSU HENGRUI PHARMACEUTICALS CO LTD2JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD1SUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD1TUOJIE BIOTECH SHANGHAI CO LTD1
Top patents by PatentIndex Score
9 records- 0187US10543284B2Anti-c-Met antibody and anti-c-Met antibody-cytotoxic drug conjugate and pharmaceutical use thereofSUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD·Filed 2016·Granted Jan 28, 2020·6 cites·36 claims
- 0254US12377163B2Anti-B7H3 antibody-exatecan analog conjugate and medicinal use thereofJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Aug 5, 2025·0 cites·40 claims
- 0354US2025000989A1Pyrrolo benzodiazepine derivative, and conjugate, preparation method and use thereofJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0452US2023054458A1Anti-claudin antibody-drug conjugate and pharmaceutical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2020·Application pending·0 cites
- 0552US2023250077A1Sulfonylbenzamide derivative and conjugate thereof, preparation method therefor and use thereofJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 0645US2023405138A1Anti-cd79b antibody-drug conjugate, and preparation method therefor and pharmaceutical use thereofTUOJIE BIOTECH SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 0744US10513510B2Toxin and method for preparing intermediate thereofJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted Dec 24, 2019·0 cites·27 claims
- 0843US2021353764A1Ligand-drug conjugate of exatecan analogue, preparation method therefor and application thereofJIANGSU HENGRUI MEDICINE CO·Filed 2019·Application pending·0 cites
- 0932US2018177890A1Ligand-cytotoxic drug conjugate, preparation method thereof, and use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jianyan Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →